Abstract |
A series of 1-[3-(4-methyl piperazin-1-ylmethyl) phenylsulfonyl]-1H- indole and 1-[3-(4-ethyl piperazin-1-ylmethyl) phenylsulfonyl]-1H- indole derivatives were designed and synthesized as 5-HT6 receptor (5-HT6R) ligands. The lead compound 1-[4-methyl-3-(4-methyl piperazin-1-yl methyl) phenylsulfonyl]-1H- indole dihydrochloride (6b), in this series, has shown potent in vitro binding affinity, selectivity, good pharmacokinetics (PK) profile and activity in the animal models of cognition.
|
Authors | Ramakrishna V S Nirogi, Thrinath Reddy Bandyala, Pamuletinarasimha Reddy Gangadasari, Mukkanti Khagga |
Journal | Journal of enzyme inhibition and medicinal chemistry
(J Enzyme Inhib Med Chem)
Vol. 31
Issue sup1
Pg. 1-15
( 2016)
ISSN: 1475-6374 [Electronic] England |
PMID | 27806648
(Publication Type: Journal Article)
|
Chemical References |
- 1-(4-methyl-3-(4-methyl piperazin-1-yl methyl)phenylsulfonyl)-1H-indole dihydrochloride
- Antipsychotic Agents
- Indoles
- Ligands
- Piperazines
- Receptors, Serotonin
- serotonin 6 receptor
|
Topics |
- Antipsychotic Agents
(chemical synthesis, metabolism, pharmacokinetics, therapeutic use)
- Cognition Disorders
(drug therapy, metabolism)
- Dose-Response Relationship, Drug
- Humans
- Indoles
(chemical synthesis, chemistry, pharmacology)
- Ligands
- Molecular Structure
- Piperazines
(chemical synthesis, chemistry, pharmacology)
- Receptors, Serotonin
(metabolism)
- Structure-Activity Relationship
|